Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00234 |
| Species: | Homo sapiens |
| Position : | chr11:5301549-5302549 |
| Year: | 2020 |
| Title: | Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | hepatocellular carcinoma |
| PMID: | 31980609 |
| MONDO: | MONDO:0007256 |
| Tissue: | Liver |
| Tissue Ontology ID: | UBERON:0002107 |
| Cell Source: | HepG2 |
| CVCL ID: | CVCL_0027 |
| Cell Type: | hepatocellular carcinoma cell |
| Cell Ontology ID: | CL:0000182 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, RNA-seq |
| Low Throughput Method: | CRISPRi, CRISPRa, Luciferase Reporter Assay |
| Target gene : | HBB |
| TF name : | FOG1; GATA1; TAL1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00321 | chr11:5301549-5302549 | Blood | chronic myeloid leukemia cell | chronic myeloid leukemia |
| E_00323 | chr11:5301549-5302549 | Peripheral Blood | T cell | adult T-cell leukemia/lymphoma |
| E_00332 | chr11:5301549-5302549 | Blood | chronic myeloid leukemia cell | chronic myeloid leukemia |
| E_00340 | chr11:5301862-5302715 | Hematopoietic system | chronic myeloid leukemia cell | chronic myeloid leukemia |